enow.com Web Search

  1. Ads

    related to: progressive supranuclear palsy treatment

Search results

  1. Results from the WOW.Com Content Network
  2. Progressive supranuclear palsy - Wikipedia

    en.wikipedia.org/wiki/Progressive_supranuclear_palsy

    Progressive supranuclear palsy (PSP) is a late-onset neurodegenerative disease involving the gradual deterioration and death of specific volumes of the brain. [ 1 ] [ 2 ] The condition leads to symptoms including loss of balance , slowing of movement , difficulty moving the eyes , and cognitive impairment . [ 1 ]

  3. Deulinoleate ethyl - Wikipedia

    en.wikipedia.org/wiki/Deulinoleate_ethyl

    In 2020, the FDA granted orphan drug designation deulinoleate ethyl for the treatment of patients with progressive supranuclear palsy (PSP). PSP is a disease involving modification and dysfunction of tau protein; mechanism of action of deulinoleate ethyl both lowers lipid peroxidation and prevents mitochondrial cell death of neurons which is ...

  4. What Is PSP? All About Progressive Supranuclear Palsy ... - AOL

    www.aol.com/psp-progressive-supranuclear-palsy...

    Lighter Side. Medicare. new

  5. Tauopathy - Wikipedia

    en.wikipedia.org/wiki/Tauopathy

    Progressive supranuclear palsy (PSP) is a type of tauopathy, but the cause is not yet discovered. For PSP unusual phosphorylation for tau protein causes vital protein filaments in the nerve cells to destruct, a phenomenon called "neurofibrillary" degeneration.

  6. Parkinson-plus syndrome - Wikipedia

    en.wikipedia.org/wiki/Parkinson-plus_syndrome

    Parkinson-plus syndromes are usually more rapidly progressive and less likely to respond to antiparkinsonian medication than PD. [10] [11] However, the additional features of the diseases may respond to medications not used in PD. [citation needed] Current therapy for Parkinson-plus syndromes is centered around a multidisciplinary treatment of ...

  7. For premium support please call: 800-290-4726 more ways to reach us

  8. Reinforced lipids - Wikipedia

    en.wikipedia.org/wiki/Reinforced_lipids

    In 2020, the FDA granted orphan drug designation RT001 for the treatment of patients with progressive supranuclear palsy (PSP). PSP is a disease involving modification and dysfunction of tau protein; RT001's mechanism of action both lowers lipid peroxidation and prevents mitochondrial cell death of neurons which is associated with disease onset ...

  9. Frontotemporal dementia - Wikipedia

    en.wikipedia.org/wiki/Frontotemporal_dementia

    Related disorders are corticobasal syndrome (CBS or CBD), and progressive supranuclear palsy (PSP). ... Treatments are available to manage the behavioral symptoms ...

  1. Ads

    related to: progressive supranuclear palsy treatment